DE69530910T2 - Medizinische zusammensetzungen enthaltend ein sialinsäurederivat - Google Patents

Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Info

Publication number
DE69530910T2
DE69530910T2 DE69530910T DE69530910T DE69530910T2 DE 69530910 T2 DE69530910 T2 DE 69530910T2 DE 69530910 T DE69530910 T DE 69530910T DE 69530910 T DE69530910 T DE 69530910T DE 69530910 T2 DE69530910 T2 DE 69530910T2
Authority
DE
Germany
Prior art keywords
sialinic
derivative
compositions containing
medical compositions
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69530910T
Other languages
English (en)
Other versions
DE69530910T4 (de
DE69530910D1 (de
Inventor
Mamoru Koketsu
Masakazu Nishizono
Teruhiko Nitoda
Yuko Enoki
Hiroshi Kawanami
Raj Juneja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyo Kagaku KK
Original Assignee
Taiyo Kagaku KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku KK filed Critical Taiyo Kagaku KK
Publication of DE69530910T2 publication Critical patent/DE69530910T2/de
Application granted granted Critical
Publication of DE69530910T4 publication Critical patent/DE69530910T4/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
DE69530910T 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat Expired - Lifetime DE69530910T4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP18669994 1994-07-15
JP18670094 1994-07-15
JP18670094 1994-07-15
JP18669994 1994-07-15
PCT/JP1995/001415 WO1996002255A1 (fr) 1994-07-15 1995-07-14 Composition medicamenteuse contenant un derive d'acide sialique

Publications (2)

Publication Number Publication Date
DE69530910T2 true DE69530910T2 (de) 2003-12-04
DE69530910T4 DE69530910T4 (de) 2005-07-14

Family

ID=26503920

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69530910T Expired - Lifetime DE69530910T4 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
DE69530910A Expired - Fee Related DE69530910D1 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69530910A Expired - Fee Related DE69530910D1 (de) 1994-07-15 1995-07-14 Medizinische zusammensetzungen enthaltend ein sialinsäurederivat

Country Status (6)

Country Link
US (1) US5834423A (de)
EP (1) EP0727216B1 (de)
JP (1) JP3930559B2 (de)
CA (1) CA2171614C (de)
DE (2) DE69530910T4 (de)
WO (1) WO1996002255A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066323A (en) * 1994-02-02 2000-05-23 The United States Of America As Represented By The Secretary Of The Army Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents
JP4316012B2 (ja) * 1996-03-26 2009-08-19 アルキオン ライフ サイエンシズ リミテッド ライアビリティ カンパニー 卵の抗炎症性組成物、単離法および使用
EP1143981B1 (de) * 1998-12-29 2006-08-09 Glukor, Inc. Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
AU2372400A (en) * 1999-01-19 2000-08-07 Dcv, Inc. Egg anti-inflammatory composition and method of treating and preventing inflammation
US20030092091A1 (en) * 2000-03-07 2003-05-15 Abrahamson Julie A. Sialoadhesin factor-2 antibodies
NL1017973C2 (nl) * 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Inrichting.
EP1420820A4 (de) * 2001-07-31 2005-04-06 Univ Texas Antigene von und antikörper gegen translozierte moleküle von mikroorganismen und ihre verwendungszwecke
US20060014717A1 (en) * 2002-06-28 2006-01-19 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
MXPA05003597A (es) * 2002-10-11 2005-06-03 Wyeth Corp Formulaciones nutricionales que contienen sustancias simbioticas.
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
HUE041502T2 (hu) * 2003-02-04 2019-05-28 Glytech Inc Eljárás aszparaginszármazékok elõállítására, amelyeknek vannak cukorláncai
CN101139624B (zh) * 2006-09-06 2012-08-22 北京德青源农业科技股份有限公司 一种制备涎酸寡糖肽的方法
UA110325C2 (en) 2009-07-03 2015-12-25 Australian Biomedical Company Pty Ltd Medicinal carbohydrates for treating respiratory conditions
WO2011027868A1 (ja) 2009-09-03 2011-03-10 公益財団法人野口研究所 １１糖シアリルオリゴ糖ペプチドの製造方法
JP5285022B2 (ja) * 2010-04-30 2013-09-11 旭化成株式会社 糖ペプチド誘導体及びその製造方法
JP5709157B2 (ja) * 2010-08-16 2015-04-30 国立大学法人 香川大学 糖鎖の製造方法
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
EP2658548B1 (de) 2010-12-31 2018-02-21 Abbott Laboratories Oligosaccharide aus muttermilch zur modulierung von entzündungen
MY174542A (en) 2010-12-31 2020-04-24 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
BR112013016905A2 (pt) 2010-12-31 2019-09-24 Abbott Lab métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano
EP3473257A1 (de) 2010-12-31 2019-04-24 Abbott Laboratories Verfahren zur verwendung menschlicher milcholigosaccharide zur verbesserung des gesundheitszustandes der atemwege
WO2012092153A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
CN104023560A (zh) 2011-08-29 2014-09-03 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
NL2007931C2 (en) 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
TW201534613A (zh) * 2013-06-28 2015-09-16 Daiichi Sankyo Co Ltd 寡糖胜肽之純化方法
EP3167889B1 (de) * 2014-07-11 2020-12-16 Tokyo University of Science Foundation Aktivatoren von immunrezeptor dendritischer zellen zur verwendung in therapie
JP6762027B2 (ja) * 2016-08-25 2020-09-30 株式会社雅嘉貿易 シアロオリゴ糖の製造方法とその利用
EP3911333A1 (de) * 2019-01-18 2021-11-24 Université catholique de Louvain Viruszusammensetzungen
WO2022191313A1 (ja) 2021-03-12 2022-09-15 第一三共株式会社 糖鎖及び糖鎖を含む医薬品の製造方法
JP2024004736A (ja) * 2022-06-29 2024-01-17 雪印メグミルク株式会社 気管支炎を予防するための栄養組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPS63221104A (ja) * 1987-03-09 1988-09-14 Rikagaku Kenkyusho ガングリオシド関連化合物及びその製造法
JPH04363302A (ja) * 1991-02-22 1992-12-16 Rikagaku Kenkyusho ポリラクトサミン型糖脂質
EP0588852A1 (de) * 1991-06-10 1994-03-30 Glycomed Incorporated Immonosuppressive und tolerogene oligosaccharidderivate
AU2807792A (en) * 1991-10-11 1993-05-03 New York University Immunoglobulin d-associated glycans and uses thereof
CA2123213A1 (en) * 1991-11-11 1993-05-27 Magnusson, Hans Goran Ganglioside analogs
JP3042738B2 (ja) * 1992-03-31 2000-05-22 雪印乳業株式会社 ガングリオシドｇｍ３組成物及びその製造法
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
JPH06145069A (ja) * 1992-11-06 1994-05-24 Nisshin Oil Mills Ltd:The ガングリオシドｇｍ３またはその類縁体を有効成分とする血管新生阻害剤
GB9422584D0 (en) * 1994-02-15 1995-01-04 Medical Res Council Immunomodulation using oligosaccharides

Also Published As

Publication number Publication date
EP0727216A4 (de) 1998-05-20
WO1996002255A1 (fr) 1996-02-01
CA2171614C (en) 2008-04-15
DE69530910T4 (de) 2005-07-14
EP0727216B1 (de) 2003-05-28
US5834423A (en) 1998-11-10
DE69530910D1 (de) 2003-07-03
CA2171614A1 (en) 1996-02-01
EP0727216A1 (de) 1996-08-21
JP3930559B2 (ja) 2007-06-13

Similar Documents

Publication Publication Date Title
DE69530910T2 (de) Medizinische zusammensetzungen enthaltend ein sialinsäurederivat
FI963421A (fi) Oraalisia apuainekoostumuksia
DE59501319D1 (de) Benzyliden-Norcampher-Derivate
DK0799297T3 (da) Fortykkede persyresammensætninger
FI952932A0 (fi) Monomeeriset insuliinianalogivalmisteet
BR9508844A (pt) Composição oral
DK0799298T3 (da) Fortykkede persyresammensætninger
BR9506536A (pt) Composição oral
NO953961L (no) Antihypertriglyseridemisk sammensetning
BR9510467A (pt) Composições orais
FI962574A0 (fi) Mikrobisidinen koostumus
BR9510307A (pt) Composições orais
EE9600011A (et) Uudsed dialkoksü-püridinüül-bensimidasooli derivaadid
BR9507768A (pt) Composição farmacêutica
NO965233D0 (no) Deacetoksytaksol-derivat
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI963631A (fi) Insektisidisia tehoainekoostumuksia
MA23731A1 (fr) Compositions detegentes
BR9509287A (pt) Composições microbicidas
DE69521745T2 (de) Diazacycloalkanalkylsulfonamid-derivat
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
BR9510459A (pt) Composições orais
NO970747D0 (no) Sammensetninger
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9502788A (pt) Comppsição inseticida